Cargando…
The National List of Essential Medicines of India 2022 (NLEM 2022): Tommy, Toe the Line
India recently released its fifth National List of Essential Medicines 2022 (NLEM 2022). A critical analysis of the list was performed and was compared with the WHO 22nd Model List of Essential Medicines published in 2021. The Standing National Committee, since its inception, have taken four years t...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305940/ https://www.ncbi.nlm.nih.gov/pubmed/37383555 http://dx.doi.org/10.1016/j.lansea.2023.100202 |
_version_ | 1785065837996015616 |
---|---|
author | Manikandan, S. |
author_facet | Manikandan, S. |
author_sort | Manikandan, S. |
collection | PubMed |
description | India recently released its fifth National List of Essential Medicines 2022 (NLEM 2022). A critical analysis of the list was performed and was compared with the WHO 22nd Model List of Essential Medicines published in 2021. The Standing National Committee, since its inception, have taken four years to finalise a list. The analysis identified that all the available formulations and strengths of the selected drugs are included in the list, which must be avoided. Furthermore, the antibacterial agents are not categorised as access, watch and reserve (AWaRe) and this list is not aligned with the national programs, standard treatment guidelines and nomenclature. There are a few factual errors and some typographic errors. These problems in the list need to be rectified immediately so that the document would be able to serve the community more effectively as a true model list. |
format | Online Article Text |
id | pubmed-10305940 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-103059402023-06-28 The National List of Essential Medicines of India 2022 (NLEM 2022): Tommy, Toe the Line Manikandan, S. Lancet Reg Health Southeast Asia Viewpoint India recently released its fifth National List of Essential Medicines 2022 (NLEM 2022). A critical analysis of the list was performed and was compared with the WHO 22nd Model List of Essential Medicines published in 2021. The Standing National Committee, since its inception, have taken four years to finalise a list. The analysis identified that all the available formulations and strengths of the selected drugs are included in the list, which must be avoided. Furthermore, the antibacterial agents are not categorised as access, watch and reserve (AWaRe) and this list is not aligned with the national programs, standard treatment guidelines and nomenclature. There are a few factual errors and some typographic errors. These problems in the list need to be rectified immediately so that the document would be able to serve the community more effectively as a true model list. Elsevier 2023-04-24 /pmc/articles/PMC10305940/ /pubmed/37383555 http://dx.doi.org/10.1016/j.lansea.2023.100202 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Viewpoint Manikandan, S. The National List of Essential Medicines of India 2022 (NLEM 2022): Tommy, Toe the Line |
title | The National List of Essential Medicines of India 2022 (NLEM 2022): Tommy, Toe the Line |
title_full | The National List of Essential Medicines of India 2022 (NLEM 2022): Tommy, Toe the Line |
title_fullStr | The National List of Essential Medicines of India 2022 (NLEM 2022): Tommy, Toe the Line |
title_full_unstemmed | The National List of Essential Medicines of India 2022 (NLEM 2022): Tommy, Toe the Line |
title_short | The National List of Essential Medicines of India 2022 (NLEM 2022): Tommy, Toe the Line |
title_sort | national list of essential medicines of india 2022 (nlem 2022): tommy, toe the line |
topic | Viewpoint |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305940/ https://www.ncbi.nlm.nih.gov/pubmed/37383555 http://dx.doi.org/10.1016/j.lansea.2023.100202 |
work_keys_str_mv | AT manikandans thenationallistofessentialmedicinesofindia2022nlem2022tommytoetheline AT manikandans nationallistofessentialmedicinesofindia2022nlem2022tommytoetheline |